Biotech Values

[biomaven0]

The Fibrogen presentation is up on retailroadshow:

http://www.retailroadshow.com/wp/roadshows.asp#

This one is a much-watch in my opinion - I believe this stock should be a core biotech holding over the next few years because I believe their HIF drug has a decent chance of completely replacing Epo (which is still an $8 billion drug despite all the restrictions on its use).

Projected IPO price is conservative I think, so a good one to grab in the IPO if you can get any.

(I've been a shareholder for many years).

Peter